US Patent Issued to KIST (Korea Institute of Science and Technology), K2B Therapeutics on Jan. 27 for "Therapeutic compounds for red blood cell-mediated delivery of an active pharmaceutical ingredient to a target cell" (South Korean, American Inventors)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,534,732, issued on Jan. 27, was assigned to KIST (Korea Institute of Science and Technology) (Seoul, South Korea) and K2B Therapeutics Inc. (Cambridge, Mass.).

"Therapeutic compounds for red blood cell-mediated delivery of an active pharmaceutical ingredient to a target cell" was invented by HoWon J. Kim (Lexington, Mass.), In-San Kim (Seoul, South Korea), Jay S. Kim (Bedford, Mass.), Sun Hwa Kim (Seoul, South Korea), Ick Chan Kwon (Seoul, South Korea), Jong Won Lee (Seoul, South Korea), Yoo Soo Yang (Seoul, South Korea) and Hong Yeol Yoon (Gyeonggi-do, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "Therapeutic compounds for red blood cell-m...